-+ 0.00%
-+ 0.00%
-+ 0.00%

Lucid Diagnostics closes USD 18 million follow-on offering of common stock

PUBT·04/24/2026 14:27:56
Listen to the news
Lucid Diagnostics closes USD 18 million follow-on offering of common stock
  • Lucid Diagnostics closed an underwritten registered direct offering of 18,000,000 common shares at USD 1 per share.
  • Gross proceeds totaled about USD 18 million, including a USD 15 million anchor investment from a fundamental institutional investor.
  • Net proceeds earmarked for working capital and general corporate purposes.
  • Canaccord Genuity, BTIG served as joint bookrunners.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lucid Diagnostics Inc. published the original content used to generate this news brief on April 24, 2026, and is solely responsible for the information contained therein.